🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting products of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Elimination

According to the social media company, the service has removed violative material and banned associated hashtags and search suggestions. The organization said it was dedicated to keeping the service secure and investing in strengthening compliance measures.

Online Trading Operations

Research also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at home.

After minutes of entering one community, a seller shared contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Pricing

Inside these communities, posts display black plastic parcels with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject patients to potentially significant health risks”.